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Abstract
Changes in the quantity of genetic material, known as somatic copy number alterations (CNAs), can drive
tumorigenesis. Many methods exist for assessing CNAs using microarrays, but considerable technical issues limit
current CNA calling based upon DNA sequencing. We present SynthEx, a novel tool for detecting CNAs from whole
exome and genome sequencing. SynthEx utilizes a “synthetic-normal” strategy to overcome technical and financial
issues. In terms of accuracy and precision, SynthEx is highly comparable to array-based methods and outperforms
sequencing-based CNA detection tools. SynthEx robustly identifies CNAs using sequencing data without the
additional costs associated with matched normal specimens.
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Background
Drivers of tumor growth, progression, and metastasis are
often a result of alterations in gene dosage and/or struc-
ture due to copy number alterations (CNAs). In breast
cancer, common disruptions of specific genomic areas
are known to drive oncogenic alterations [1]. Previous
research has identified key drivers in a subtype-specific
manner that are a direct result of CNAs rather than
somatic point mutations. These acquired genomic alter-
ations can foster the activation of oncogenes or inactiva-
tion of tumor suppressors in cancer cells [2]. CNA
detection has also previously identified therapeutic
targets across multiple cancer types [3–6]. The clinical
importance of accurately measuring CNAs is critical to
understanding the biologic progression of cancer.
Previous efforts to identify CNAs in tumors utilized
microarray-based technologies, such as array comparative
genomic hybridization (aCGH) and single nucleotide
polymorphism (SNP) genotyping arrays. Currently, next-
generation sequencing approaches enable a comprehen-
sive survey of all genomic variations in one sample.
Furthermore, whole exome sequencing (WES) is a popular
tool for cancer genomics projects as it involves a reduc-
tion in analytical complexity and financial burden com-
pared to whole genome sequencing (WGS). With efforts
from large sequencing consortia, such as The Cancer
Genome Atlas (TCGA) project [7], WES data for thou-
sands of tumors spanning a multitude of cancer types
are currently available. Harnessing these technologies
to accurately identify CNAs in tumor samples provides
a powerful opportunity for additional research using
these data.
Significant technical challenges in the detection of
CNAs from sequencing platforms currently limit the use
of WES data for accurate DNA copy number
characterization. Errors in the human reference genome,
repetitive sequences, polymorphism, and procedural bias
during next-generation sequencing currently complicate
copy number calling [8]. For WES data specifically,
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accurate copy number segmentation is further compli-
cated by non-uniform capture efficiency of exons be-
tween two samples. Two generalized approaches to
detect CNAs from WES include: reliance on depth of
coverage from target regions, thus ignoring a large por-
tion of the genome [9–13]; and utilizing uniformly dis-
tributed off-target reads [14], thus ignoring the signal
necessary for sophisticated analyses such as estimation
of integer copy number, sample purity, and clonality. To
address these issues, we developed a method that lever-
ages information from both off-target and on-target
regions.
Previously published algorithms have attempted to ad-
dress the challenges of detecting CNAs from WES; how-
ever, to our current knowledge none has provided a
comprehensive solution with the additional ability to re-
duce the current high cost of requiring matched nor-
mals. We developed SynthEx, a tool that caters to the
varying protocols of different next-generation sequen-
cing protocols, to detect CNAs. SynthEx uses a
“synthetic-normal” strategy to correct for sample-
specific bias in target regions due to pre-analytical vari-
ation between tumor–normal matched pairs. Therefore,
instead of requiring a matched tumor–normal paired
sample from each subject, a synthetic normal is used that
mimics the technical bias of the tumor to be assayed.
Using published CNAs by TCGA from Affymetrix SNP
6.0 as the “gold standard”, we compared the performance
of SynthEx against popular WES CNA detection methods
[9, 11, 15], using TCGA breast carcinoma as the training
set and TCGA head and neck carcinoma as the test set.
Here, we provide a novel copy number calling tool utiliz-
ing WES data with improved precision and accuracy that
does not require matched normal specimens.
Results
Sample-specific bias of read ratios in exonic/target
regions due to fold enrichment differences
To explore new methods for assessing copy number
alterations (CNAs) using short read DNA sequencing
data, we utilized whole exome sequencing data from 989
TCGA breast tumors and matched normal specimens
(Additional file 1) [16].
One significant challenge in calling CNAs from whole
exome and targeted sequencing is how to use the infor-
mation and accurately predict copy number from off-
target regions. We first explored the differences in non-
overlapping bin sizes in order to have >50× coverage in
each bin (Additional file 2: Figure S1). Utilizing 100-kb
non-overlapping bins to maximize the coverage in our
exploratory analysis, we first examined whether the ra-
tios of matched tumor-to-normal, or the read ratios
(RRs), from target regions had a similar distribution in
the on-target and off-target regions. If this was true,
then one could directly apply existing change point
methods developed for SNP array data to non-
overlapping bins.
We calculated the RRs for each matched tumor–normal
pair at each 100-kb non-overlapping bin. For each pair of
adjacent bins, we calculated the difference of the read ra-
tios (RDs; an abbreviation for ratio difference). Each pair
of adjacent bins was then categorized into three categories
based on the exon target regions: adjacent on-target bins,
adjacent off-target bins, or an off-target bin adjacent to an
on-target bin (Fig. 1a). Mapping the distribution of RDs
from these three categories resulted in three different pat-
terns (Fig. 1b–d): 1) RDs in the adjacent bins followed the
same distribution, resulting in the density curves of the
RD centralizing at 0 and having the same shapes (Fig. 1b);
2) the three bin categories followed different distributions,
causing the density curves of the RDs to not centralize at
0 (Fig. 1c); or 3) the three bin categories followed different
distributions, causing the density curves of the RDs to
centralize on 0 but not share the same shape (Fig. 1d).
The varying behavior in the density of RD from TCGA
samples indicates that the RR of matched tumor–normal
from target regions cannot directly compare with that
from non-target regions.
To interrogate the cause of this variation, we first ex-
amined the GC content of the predicted copy number
neutral bins. We observed a largely uniform distribution
with minimal non-uniformity at the tail (GC >0.5). This
non-linear pattern and inconsistency indicates patterns
that may be due to other non-GC factors. Next, we per-
formed single variable regression analysis of the differ-
ence in matched tumor–normal for 16 quality metrics
from Picard to identify the variance of the RD as a
function of these different metrics (Additional file 2:
Figure S2; Additional file 3: Table S2). The coefficients
of determination varied from 0.001 (GC dropout) to
0.31 (fold enrichment) (Additional file 2: Figure S3a).
Interestingly, fold enrichment was also highly correlated
with roughly half of the other Picard metrics (Additional
file 2: Figure S3b). Here, fold enrichment is defined as
the amount of fold change in which the target region is
amplified above genomic background. As fold enrich-
ment during whole exome capture differs between the
tumor and matched normal, the distribution of RD in
the target bins shifted with respect to their adjacent off-
target bins (Fig. 1e).
A second important variable in altering the RD was
the differences in library size. When the library sizes of
the tumor and matched normal differed significantly, a
greater standard deviation was observed (Fig. 1f ). Taken
together, library size and fold enrichment are two signifi-
cant factors contributing to the technical bias introduced
when comparing tumor to matched normal for quantifi-
able copy number calling.
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Creating a synthetic normal library
In order to address the technical bias created by differ-
ences in library size and capture efficiency in whole ex-
ome DNA sequencing, we utilized a synthetic normal
strategy to replace matched normal. We began by per-
forming unsupervised hierarchical clustering of the
mean-centered coverage of the top 2500 exons with the
largest variance across the 989 TCGA breast normal set
(Fig. 2). Normal samples are assumed to be diploid, and
thus we hypothesized that any resulting structure is indi-
cative to technical biases. Seven distinct patterns of
coverage across these exons were noted in the unsuper-
vised clustering (i.e., not supervised by knowledge of
protocol differences). We then investigated whether
these were differences due to processing features.
Protocol versions of Nimblegen v 2.0, Nimblegen v 3.0,
and Agilent SureSelect technologies were specifically
associated with different clusters, highlighting that even
different versions of exon capture protocols can affect
targeted capture efficiency. Additionally, the type of ini-
tial analyte used significantly grouped with specific clus-
ters (Fig. 2a, color bar).
We anticipated that matching tumors to normal based
on library size and fold enrichment may reduce technical
variation relative to the actual subject’s matched normal.
Within each of the seven exome clusters identified
through hierarchical clustering, we grouped normal sam-
ples by library size and fold enrichment (Fig. 3a). For
each bin, we averaged the normal samples within that
bin to generate a representative “synthetic” normal. To
call CNAs from a tumor sample, we first calculated the
fold enrichment and library size of the tumor. Then we
selected the synthetic normal with similar fold enrich-
ment and library size from each of the seven exome
a
b c d
e f
Fig. 1 Sample-specific bias of read ratios due to sequencing quality metrics of the tumor–normal pair. a The three types of adjacent bins.
Differences in ratio density (RD) of adjacent bins spanning on-target regions, off-target regions, or both demonstrating b similar distributions,
c dissimilar distributions not centered at 0, or d dissimilar distributions centered on 0. e Mean RD compared to the difference of fold enrichment
(log10 scale) between the tumor–normal pairs for 989 TCGA breast cancer samples. f Standard deviation of the RD compared to the difference in
the library size (×106) for 989 TCGA breast cancer samples
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groups. Finally, we compared the variance of the tumor
to each of the possible seven synthetic normals from the
previously defined exome groups and selected the syn-
thetic normal with the least variance. Thus, the SynthEx
Synthetic method utilizes the most ideal pooled syn-
thetic normal based on library size and fold enrichment.
In order to test for differences between subject matched
and SynthEx Synthetic, we assume RR to be a piecewise
constant function of genomic location and measure the
magnitude of variation with the mean square successive
difference (MSSD) to represent the amount of technical
bias. The mean MSSD for all 989 TCGA breast cancer
samples is lowered from 0.09 to 0.02 when using a syn-
thetic normal versus using the matched normal sample
(Fig. 3b; one-sided Wilcoxon test, p value <2.2e-16).
Specifically, 90% of the tumor samples (n = 896) have an
improved MSSD value. Furthermore, there’s a striking
difference and reduction of noise in the RR plots of two
tumors analyzed using a matched normal (Fig. 3c, e) ver-
sus using a synthetic normal (Fig. 3d, f ).
Varying bin sizes
To assess the robustness of SynthEx Synthetic to bin sizes
at varying library sizes (8–30 million reads), we evaluated
the performance of our method at 10-, 20-, 50-, and 100-
kb non-overlapping bins. We first calculated the percent-
age of tumors which had at least 20 reads in 90% of the
bins (Additional file 2: Figure S1). At 10-kb resolution,
49% of samples have at least 20 reads in ≥90% quantified
bins. At 20-kb resolution, 78% of samples have sufficient
coverage in 90% quantified bins. At 50 kb, the coverage
plateaus with 93% of samples having adequate coverage.
Furthermore, the MSSD at each overlapping bin size sig-
nificantly decreases with increasing bin size (Additional
file 2: Figure S4a; ANOVA p value <2e-16). This suggests
that 10- and 20-kb bin sizes may not adequately span the
genomic space to accurately call CNAs.
We next tested our original assumption that 100-kb bin
sizes, which provided the highest coverage of the genome
with 50× coverage per bin, was an improvement over 10-,
20-, or 50-kb bins. We calculated Jaccard Index (JI), sensi-
tivity, and specificity relative to Array SNP CNA segments
as statistical evaluations of the precision and accuracy of
our tool (Additional file 2: Figure S4b–d). ANOVAs dem-
onstrate no significant difference for all three statistical
measures across the various bin sizes, although there is a
trend of a slight trade-off of sensitivity and specificity
when comparing 10 to 20 kb and 50 to 100 kb (ANOVA
p value: JI = 0.63; sensitivity = 0.96; specificity = 0.871).
Alternative approaches using the synthetic normal
strategy
We investigated utilizing the K nearest neighbor
(KNN) strategy as an alternative approach to generating a
Fig. 2 Hierarchical clustering of the top 2500 most variable exons in TCGA breast normal. Unsupervised hierarchical clustering of mean-centered
coverage of the 2500 exons with the highest variability across the 989 TCGA normals. Color bars indicate protocol differences (black = Agilent,
white = Nimblegen v 2.0, red = Nimblegen v 3.0) and analyte type (gray =whole genome amplification, white = DNA). Groups defined by hclust are
identified by color in the bottom row
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new synthetic normal without using fold enrichment in-
formation. Given a tumor sample, we scan through all of
the available normal samples, calculate the MSSD for each
normal, and select “K” normals with the smallest variance
MSSD value. SynthEx then generates the new synthetic
normal by taking the median across the K selected nor-
mals. This generated synthetic normal is then used with
the tumor sample for copy number determination. We
call this the K nearest neighbor (KNN) strategy. Com-
pared to using SynthEx Synthetic with the large library of
synthetic normals, this approach is more appropriate for
studies with few normal samples or for a facility where the
protocol is constantly changing.
For TCGA BRCA samples (989), copy number for
each tumor was re-calculated using a synthetic normal
generated from K = 5 normals. Variance was calcu-
lated by MSSD, and these values were compared to
MSSD when using a library of pre-defined synthetic
normal as described above. MSSD values were highly
correlated (Fig. 4a; R2 = 0.924; one-sided Wilcoxon test,
p value = 0.0677). This indicates KNN can be used as a
generalization of the cluster-based solution.
We again explored whether 100 kb was the appropri-
ate bin size. Using 10-, 20-, 50-, and 100-kb non-
overlapping windows with K = 5, we tested the KNN
method compared to the synthetic normal strategy,
calculating JI, sensitivity, and specificity compared to
Array SNP CNA as the gold standard (Fig. 4b–d). There
is a significant improvement of the JI with increasing bin
size (ANOVA of KNN bins p value = 0.021, F = 3.272) as
a b
c
d
e
f
Fig. 3 Generation of synthetic normal and improvement of technical noise with synthetic normal. a Library size and fold enrichment of TCGA
normals. Each color represents the normal utilized in generating the synthetic normal for that bin. b Comparison of mean square successive
difference calculated by using a matched normal (y-axis) or a synthetic normal (x-axis) for all 989 TCGA breast cancer samples, with tumors from
c–f marked in red. Read ratios plotted by genomic location of two TCGA breast cancers and normals from the same patient (a, c) compared to
read ratios calculated from the same two tumors using a synthetic normal (b, d)
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well as a slight trade-off of bin size for sensitivity
(ANOVA of KNN bins p value = 0.023) but not specifi-
city (ANOVA of KNN bins p value = 0.855).
Concordant copy number calling with SynthEx
To evaluate the performance of our synthetic normal
strategy relative to previously published methods, we
compared a subset of TCGA breast tumor CNAs assayed
by three platforms: Affy SNP 6.0 (SNP), whole exome se-
quencing (WES), and whole genome sequencing (WGS)
platforms (“BRCA”, n = 92; Additional file 1: Table S1)
[17]. BRCA WGS SynthEx CNA landscape plots more
closely resemble SNP CNA landscape plots than plots
created using the TCGA WGS CNAs from tumor–normal
matched pairs (Additional file 2: Figure S5). Furthermore,
less noise is observed in the WGS CNA landscape plot
from SynthEx compared to the TCGA WGS CNAs land-
scape plot (Additional file 2: Figure S5b,c).
The same 92 BRCA patient WES data were analyzed
with VarScan2 [15], ADTEx [9], and Control-FREEC
(Table 1, Fig. 5) CNA detection tools. CNAs determined
from Affy SNP data are used as the gold standard to
which all WES CNA detection tools are compared.
Genome-wide CNA frequency landscape plots from
SynthEx, VarScan2, ADTEx, and Control-FREEC pro-
duced similar plots as the SNP-based copy number
a
c
b
d
Fig. 4 Varying bin sizes for the synthetic normal and K nearest neighbor. Copy number ratios were calculated from the K nearest neighbor
strategy for K = 5 at varying bins and compared to SynthEx Synthetic (composite synthetic normal) using: a the mean square successive
difference at 100-kb non-overlapping bin sizes; b the Jaccard Index; c sensitivity; and d specificity using SNP array as the ground truth at 10 (red),
20 (blue), 50 (green), and 100 kb (purple)
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landscape plot (Fig. 5). Furthermore, expected regions of
frequently occurring copy number gains at 1q and 8q
and copy number losses at 1p, 5q, and 8p were also
identified across all landscapes plots from both WES
and WGS data (Fig. 5; Additional file 2: Figure S5).
Genes whose discrete copy number calls differed sig-
nificantly from the discrete SNP gene-level copy num-
ber by Wilcoxon tests are highlighted (Fig. 5) and
quantified (Fig. 6a, b). Discrete gene-level copy num-
ber calls using SynthEx shared a 98% overlap with
SNP array-based calls, with 334 genes discordant be-
tween SNP and SynthEx and five of these genes annotated
within the Cancer Gene Census [18]. ControlFREEC
(69%), VarScan2 (60%), and ADTEx (55%) shared less
overlap with the gene-level CNAs from SNP arrays. Of
the genes discordantly called in each software, 1703 were
consistently miscalled among ADTEx, VarScan2, and
ControlFREEC (Fig. 6b). Furthermore, noticeable varia-
tions in the percentage of observed copy number gains
versus copy number losses occurred across the different
WES methods, with SynthEx calls most closely resembling
the fraction of CNAs produced by SNP (Fig. 6c). Finally,
each method produced varying copy number segment
sizes, with SynthEx having a fixed bin size of 100 kb
(Fig. 6d).
Assessing precision and accuracy of segments of SynthEx
To quantify the precision and accuracy of SynthEx com-
pared to the other WES CNA detection tools, the JI,
sensitivity, and specificity were calculated at 100-kb
non-overlapping bins (Additional file 4: Table S3). In
BRCA, comparing each method to the SNP CNAs, the
median JI values are highest for SynthEx KNN (0.622) and
SynthEx Synthetic (SynthEx SN; 0.526), with ADTEx
following (0.418) (Fig. 7a, one-sided t-test ADTEx v.
SynthEx SNp = 4.9e-5; ANOVA p = 1.7e-8). VarScan2 and
ControlFREEC have lower JI values (VarScan2, 0.380;
ControlFREEC, 0.390). SynthEx also outperformed the
other copy number detection WES tools within the
BRCA genomically defined and clinically heteroge-
neous breast cancer subtypes (Additional file 2: Figure S6),
which have known variations in CNAs and genomic
drivers [19, 20].
The median sensitivity of the WES CNA detection
tools compared to SNP-based CNAs demonstrates a
modest improvement using SynthEx KNN (0.88),
SynthEx Synthetic (0.84), and ADTEx (0.77; one sided
t-test p = 0.40) but a significant improvement compared to
Control-FREEC (0.69; p = 2.5e-4) and VarScan2 (0.65; p =
2.4e-7) (Fig. 7b; overall ANOVA p = 0.00029). The median
specificity follows a similar pattern, with SynthEx KNN
and SynthEx Synthetic outperforming the other callers
(Fig. 7c; SynthEX KNN, 0.91; SynthEx Synthetic, 0.90;
VarScan2, 0.80; Control-FREEC, 0.80; ADTEx, 0.79;
one-sided t-test p < 2.5e-10; ANOVA p = 0.0055). In
addition, SynthEx Synthetic continued to outperform the
other WES detection tools in terms of median sensitivity
and specificity when the comparison was subdivided
into the intrinsic breast cancer molecular subtypes
(Additional file 2: Figures S7 and S8). Finally, for all
bin sizes, both the KNN and Synthetic strategies out-
perform previously published WES detection tools
ADTEx, VarSacn2, and Control-FREEC (Additional file 2:
Figure S9).
To further assess the robustness of SynthEx, we com-
pared the WES tools and SNP arrays using the TCGA
WGS CNAs as the gold standard (Additional file 5:
Table S4). For each measurement of precision or accur-
acy, SNP and SynthEx Synthetic were not significantly
different from one another (all one-sided t-tests SNP
versus SynthEx >0.94). For the median JI, SNP (0.61),
Synthex KNN (0.57), and SynthEx Synthetic (0.47) out-
perform the other WES copy number tools (Figure 7d;
Control-FREEC, 0.35; ADTEx, 0.34; VarScan2, 0.33;
Table 1 Comparison of somatic copy number detection tools from whole exome sequencing data
ADTEX Control-FREEC SynthEx VarScan2
Programming language R, Python C++ R, Python Java, Perl, R
Sequencing type WES WES/WGS WES/WGS WES
Input files BAM, coverage SAM/BAM, pileup BAM BAM, pileup
Matched normal required Yes No No Yes
Window/binning Exons Non-overlapping windows
in exons
Non-overlapping windows
of genome
Non-overlapping windows
in exons
Bias correction No Optional NA No
Purity estimate No Optional YES with variant calling No
Segmentation method CBS Lasso CBS CBS
Segmentation annotation Yes Yes Yes Yes
Graphics provided Yes Yes Yes Yes
CBS circular binary segmentation
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ANOVA p < 2e-16). SynthEx KNN (0.77), SynthEx Syn-
thetic (0.71), and SNP (0.76) outperform all other
methods in terms of median sensitivity (Fig. 7e; ADTEx,
0.66; Control-FREEC, 0.58; VarScan2, 0.58; ANOVA p =
5.4e-9). Finally, all CNA detection tools have extremely
high median specificity compared to WGS CNAs, with
SynthEx and SNP significantly different to the other
methods (Fig. 7f; SNP, 0.92; SynthEx KNN, 0.88; SynthEx
Synthetic, 0.86; Control-FREEC, 0.82; VarScan2, 0.80;
ADTEx, 0.79; ANOVA p = 1.5e-8).
Assuming that the normals collected in TCGA breast
dataset were diploid, we tested the false positive rate of
the SynthEx Synthetic caller. SynthEx Synthetic at 100-
kB bin size called a median of 0.0083 bins in the human
genome as altered (0.0080–0.02 bins).
Validation of SynthEx in TCGA head and neck squamous
cancers
To validate the findings seen for the BRCA dataset, we
repeated the above analyses using a subset of TCGA
a
b
c
d
e
Fig. 5 CNA genomic landscape comparing SNP arrays and whole exome sequencing tools in TCGA breast cancers. Using SWITCHplus, segments
of copy number gained (above x-axis) and lost (below x-axis) are plotted from a SNP array, b SynthEx, c VarScan2, d ADTEx, and e control-FREEC.
The frequency of an alteration out of the 92 tumors analyzed in each tool is indicated on the y-axis from 0–100%. Regions in red (gains) or green
(loss) indicate segments that contain at least one gene whose discrete copy number alteration direction call is significantly different from SNP by
Wilcoxon test
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head and neck squamous cellular carcinomas with both
SNP and WES platforms (“HNSC”; n = 100; Additional
file 6: Table S5). SynthEx HNSC CNAs most closely
match the SNP copy number landscape plots compared
to plots generated from VarScan2, ADTEx, and Control-
FREEC (Additional file 2: Figure S10). Previously pub-
lished highly frequent copy number gains at 3q, 5p, and
8q and copy number losses at 3p and 8p were observed
in the HNSC copy number landscape plots. Discrete
gene-level copy number calls using SynthEx shared a
97% overlap with SNP-based gene level copy number
calls within HNSC (Additional file 2: Figure S10).
Examining the variation in bin size for HNSC, we next
compared the KNN and synthetic normal strategies. No
significant differences were observed for JI, sensitivity, or
specificity at varying bin sizes or with the different strat-
egies (Additional file 2: Figure S11a-c).
Examining the same statistical metrics using SNP ar-
rays as the gold-standard, SynthEx’s performance was
competitive with other WES CNA tools (Additional
file 7: Table S6) that require matched normals. The
median JI was higher in SynthEx KNN (0.71) and
SynthEx Synthetic (0.67) compared to the other WES
CNA detection methods (Additional file 2: Figure S11d;
ANOVA p < 2e-16; one-sided t-test versus VarScan2
p = 4e-14). Although the median sensitivity of VarScan2
(0.94) and ADTEx (0.97) slightly out-performed SynthEx
KNN (0.93) and Synthetic (0.93) in the HSNC cohort, all
three values are extremely high and not statistically dif-
ferent (Additional file 2: Figure S11e; one-sided t-tests:
SynthEx Synthetic versus VarScan2 p = 0.99; SynthEx
Synthetic versus ADTEx p = 0.99; SynthEx Synthetic versus
ControlFREEC p = 6.8e-16). In addition, SynthEx KNN
(0.94) and Synthetic (0.95) outperformed the other WES
copy number tools in terms of specificity (Additional file 2:
Figure S11f; ANOVA p = 6.6e-11; one-sided t-tests, SynthEx
versus VarScan2 p = 1.1e-15, SynthEx versus ADTEx
p < 2.2e-16, SynthEx versus ControlFREEC p < 2.2e-16).
a
c
b
d
Fig. 6 Quantification of differences in CNA calls from the WES CNA detection tools. For each tool, a the number of genes significantly different
compared to SNP arrays and b the overlap of those genes across platforms. c Proportion of all calls that are copy number gains and copy
number loss segments called by each WES CNA detection tool. d Lengths of copy number segments detected by each WES CNA detection tool
compared to the SynthEx synthetic normal strategy using 100-kb non-overlapping bins
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Cumulatively, SynthEx outperforms the other WES CNA
detection tools in a reproducible manner.
Discussion and conclusions
We present SynthEx, a novel tool that detects CNAs
from both whole genome and whole exome sequencing
(WES) data by comparison to a synthetic normal. We
strongly emphasize the differences in exon capture
patterns observed both across and within protocols,
which must be considered when utilizing sequencing
data for CNA calling. We demonstrate that SynthEx out-
performs ADTEx, Control-FREEC, and VarScan2 CNA
detection tools in both accuracy and precision.
Our experience suggests that technical variation in
WES goes beyond differences in experimental protocols.
Utilizing read ratios (RRs) to call copy number
a b c
d e f
Fig. 7 Jaccard Index, sensitivity, and specificity of SynthEx. Statistics of CNA tools from whole exome sequencing (WES) methods SynthEx KNN
(black), SynthEx Synthetic (SN, red), VarScan2 (blue), ADTEx (green), and ControlFREEC (purple) compared to SNP arrays (a–c) and whole genome
sequencing (WGS) (d–f) in TCGA breast cancer dataset. Compared to SNP arrays, one-sided t-tests tested SynthEx SN to the next highest mean to
determine significance for a Jaccard Index (SynthEx SN versus ADTEx p = 4.9e-5), b sensitivity (SynthEx SN versus ADTEx p = 0.40), and c specificity
(SynthEx SN versus VarScan2 p = 5.6e-10). Overall mean differences were significant in all plots as measured by ANOVA (Jaccard Index p = 1.7e-8,
sensitivity p = 0.00029, specificity p = 0.0055). Compared to WGS, SNP (gold) and SynthEx KNN and SynthEx SN outperformed the other WES callers:
d Jaccard Index (ANOVA p < 2e-16), e sensitivity (ANOVA p = 5.4e-9), and f specificity (ANOVA p = 1.5e-8). No statistical differences between SNP
and SynthEx SN were measured in d–f (one-sided t-test p > 0.94)
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alterations has an underlying assumption that generation
of the on-target and off-target regions have non-
significant variation in the tumor and matched normal.
Here, we demonstrate that accounting for this technical
noise is critical to accurately determine CNAs from next-
generation sequencing technologies. SynthEx provides a
robust method to handle technical variation and a collec-
tion of heterogeneous normal samples. To the best of our
knowledge, SynthEx is the first tool that utilizes a match-
ing synthetic normal based on the consistency of target se-
quencing profiles to detect sequence-based CNAs.
Many advantages for cancer researchers may exist
when utilizing SynthEx over other WES CNA detection
methods. The robust synthetic normal strategy does not
require a matching normal sample for each tumor sam-
ple, thereby potentially reducing sequencing costs by
half. Additionally, SynthEx uses both on-target and off-
target reads and is thus able to accurately determine
copy number across the entire genome. Finally, the use
of a synthetic normal with similar quality metrics as the
tumor being interrogated leads to superior performance
compared to using the matched normal for both WES
and WGS copy number data.
SynthEx requires some normals to be sequenced with
the same protocol and/or generated by the same sequen-
cing facility as the tumors to which they are compared. If
a large pool of samples is available (i.e., in large consortia
like TCGA), then the pooled synthetic normal strategy
can be employed. For smaller datasets, the KNN strategy
can be used. Given a tumor sample, SynthEx will select
the best normals that minimize the technical variability of
a pair. The performance of SynthEx is not guaranteed if
using normals generated by different protocols.
In this post-data collection era of TCGA project, we
foresee that many studies will integrate multiple TCGA
DNA sequencing samples that are processed by different
protocols. Additionally, we foresee that large consortia
will encounter similar issues with changes in protocols
over time. Thus, it will be necessary to closely examine
technical artifacts when performing any quantitative
analysis, especially in the context of copy number detec-
tion. Recognizing that CNAs are essential steps in
tumorigenesis and metastasis in many tumor types, it is
critical to robustly and accurately determine CNAs from
sequencing data. SynthEx offers a unique solution for
analysis of heterogeneous samples from large genomics
projects in this regard.
Due to the inherently heterogeneous, interrupted
coverage of the genome by targeted/whole exome se-
quencing, sequencing reads are not evenly distributed
across the genome. To utilize information from off-
target regions, SynthEx uses a generous fixed bin size
(10–100 kb) to make sure each bin has adequate cover-
age (for samples with 8–30 million reads). Lower
resolutions could provide CNAs within a single gene,
though there is an increasing amount of noise. Even at a
resolution of 10 kb, SynthEx outperforms alternative
methods compared with SNP array-based calls at both
the base-pair and discrete gene level.
A significant limitation of SynthEx is the inability to
identify focal changes or aberrations that span only sev-
eral hundred base pairs. This could be alleviated by
introducing adaptive bin sizes. Several algorithms have
been developed to accommodate the non-uniformity of
read distribution. For example, Zhao et al. [21] proposed
a “restriction-imposed” flexible binning algorithm, which
generated bin sizes locally to ensure even variance as
well as adequate number of reads per window. A similar
algorithm has been applied in Ginkgo [22], a recent copy
number calling method for single-cell sequencing data.
Extending our framework to generate adaptive bin sizes
and assessing the potential benefits is a promising av-
enue for future research.
Compared to conventional copy number analysis,
which usually estimates the total copy number for a
given genomic window, allele-specific copy number ana-
lysis (ASCN) is becoming increasingly popular due to its
promise in clonality analysis [23–25]. ASCN methods re-
quire read counts and allele frequency at each single nu-
cleotide as input data to infer high-resolution allele-
specific copy number and accurate tumor purity/ploidy.
It is worthwhile to investigate whether the synthetic nor-
mal strategy can enhance the power of ASCN methods
by reducing unwanted variation at the single nucleotide
level. Combining SynthEx with ASCN procedures is
likely to be another fruitful future direction.
Methods
Breast cancer tumor datasets
For these comparative studies, two human datasets were
used: the training dataset contains breast carcinoma data
collected by TCGA and available via TCGA data portal
(BRCA, n = 92) and the validation dataset contains head
and neck squamous cell carcinomas collected by TCGA
(HNSC, n = 100). The synthetic normal dataset is com-
prised of 989 matching normal WES samples from a lar-
ger available TCGA BRCA tumor cohort. Detailed
biospecimen collection and sample processing informa-
tion, including sample inclusion criteria, sample process-
ing, and clinical data quality assessment of biomarkers,
have been previously described [1, 26]. Demographic
and clinical information is available (Additional file 1:
Table S1).
For both BRCA and HNSC tumor samples, SNP and
DNA WES data were collected from TCGA data portal.
In addition, DNA WGS data were collected from a
subset of matched tumor–normal BRCA samples [17].
For SNP data, the publically available level 3 circular
Silva et al. Genome Biology  (2017) 18:66 Page 11 of 14
binary-segmented copy number data were downloaded
from TCGA data portal. For WES, burrows-wheeler
aligner (BWA) aligned BAM files were acquired from
TCGA and realigned using an assembly-based re-aligner
(ABRA) with the default parameters [27, 28].The
genotype-calling pipeline was built using Freebayes [29].
For WGS, BWA alignments of paired 100-nucleotide
reads were acquired from TCGA and processed as previ-
ously described [16, 17].
Calculating variability and quality assessment of
sequence experiments
Using the ABRA re-aligned BAM files, we calculated
read ratios (RR) in the tumor and paired normal sample
for each 100-kb non-overlapping bin. Bins are classified
as target bins if the bin overlaps with any selectively
amplified targets. Bins that do not overlap any selective
amplified targets are labeled as off-target bins. Further-
more, bins are also grouped into adjacent bins. Then,
each pair of adjacent bins is divided into three categor-
ies: two-adjacent target bins, two adjacent off-target
bins, or a target bin adjacent with an off-target bin. The
variability is assessed by ratio difference (RD), calculated
as the difference of the RR between the two bins that
comprise the adjacency bins. For each sample, the distri-
bution of RD is plotted and mean and variance are
calculated.
Using Picard (http://broadinstitute.github.io/picard/),
we collected various sequence-based metrics, including
fragment length, sequence content, alignment, capture
bias and efficiency, coverage, variant call metrics, and fold
enrichment. Fold enrichment is defined as the amount of
fold change in which the baited region is amplified above
genomic background (http://broadinstitute.github.io/
picard/). We performed regression analysis using the
lm function in R v.3.3.0 on each collected metric relative
to the mean of RD to determine any association between
the RRs and the various quality metrics. In addition, the
median minor allele frequency (MAF) is calculated for
each bin. Bins with a median MAF greater than 0.45 are
candidate copy neutral events. A Gaussian mixture model
for RR and a Bayesian Information Criteria (BIC) are used
to determine the copy number state and identify diploid
bins. We assign the mixture component with the smallest
mean RR as diploid. The RRs in all bins are adjusted so
that the diploid regions have expected RR equal to 1. To
assess the quality of the genotype calling method, we ex-
amined the exon regions covered by WES and SNP array
technologies.
Copy number calculation from synthetic normal and
purity estimation
Using the BRCA WES normal samples, we created syn-
thetic normal WES profiles that cover a spectrum of fold
enrichment levels and library size levels. For each library
size and fold enrichment, we averaged the normal sam-
ples that fall into that given bin. For a given tumor sam-
ple, we first analyzed the fold enrichment and library
size, then searched for a matching synthetic normal. To
account for samples with aneuploidy, we identified the
diploid genome within the tumor sample by gauging in-
formation from allele frequencies of heterozygous sites.
We used the circular binary segmentation (CBS) algo-
rithm to identify significant change-points across RR
bins and identify segment-level CNAs [30].
To accurately estimate purity, we refined a previously
published WGS computational framework, SomatiCA
[31]. We implemented SomatiCA’s fully specified Bayesian
normal mixture model to assign each segment an integer
copy number based on posterior probabilities. We further
utilized several heuristic-based filters to assist the assign-
ment of integer copy numbers which threshold the mini-
mum number of segments in each integer copy level
(gains >.25; losses <-.32 in log2 transformed ratios) and
identify the minimum distance in MAF between two copy
number levels.
Selection and processing of algorithms to detect somatic
copy-number alterations
We compared SynthEx against published algorithms that
detect CNAs from cancer genome sequence information.
Using a comparative-based literature search for top scor-
ing CNA detection tools resulted in three algorithms:
ADTEx [9], ControlFREEC [11], and Varscan2 [15].
Table 1 highlights the main features of the selected algo-
rithms and our new tool. The dominant strategy to detect
CNAs from WES data is to identify change points in the
RR counts or depth of coverage ratios between a tumor
and its paired normal sample at local genomic regions.
ControlFREEC and VarScan2 use non-overlapping bin-
ning windows in exons to infer raw copy numbers,
whereas ADTEx uses exon regions. Furthermore, Control-
FREEC performs GC content normalization and mapp-
ability bias correction when inferring copy numbers.
Segmentation is performed following the initial copy num-
ber identification to identify regions of the genome with
shared copy number values. ADTEx and VarScan2 use
CBS whereas ControlFREEC uses a lasso-based algorithm
to delineate segments of similar copy number.
We applied ADTEx v.1.0.4 with default settings. We ap-
plied Control-FREEC v.7.2 with the following configuration:
coefficientOfVariation = 0.05, breakPointThreshold = 0.8,
window= 50000, intercept = 0, contaminationAdjustment =
TRUE. VarScan2 v2.2.4 was run with mpileup default
parameters: -q 1 -f ref.fa normal.bam tumor.bam | java -jar
VarScan.jar copynumber varScan –mpileup 1; java -jar
VarScan.jar copyCaller varScan.copynumber –output-file
varScan.copynumber.called
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[–output-homdel-file varScan.copynumber.called.hom-
del] such that the output is in log2 transformed space
and comparable to SNP Array.
Statistical analysis
To evaluate the ability of SynthEx to detect CNAs (i.e.,
gain or loss of genomic DNA), we compared WES and
WGS SynthEx segment-level and gene-level copy num-
ber value against CNAs produced from genome-wide
SNP arrays and against WES copy number detection
tools, including ADTEx, ControlFREEC, and VarScan2.
Discrete gene-level copy number calls are created using
modification from SWITCHplus [19]. Specifically, we
assigned 1 to all significant copy number gained seg-
ments identified through CBS and −1 to all significant
segments of copy number loss identified through
CBS; all other segments were labeled 0. Using the
copyNumberHeatmap and createCNGeneHeatmap func-
tion from SWITCHplus we created copy number gene
matrices for each copy number detection tool and each
dataset.
Multiple statistical tests were used to assess the accur-
acy and precision of CNAs identified using SynthEx
against other WES, WGS, and SNP-based copy number
detection algorithms. Gene-level Wilcoxon tests were
performed for each gene in the discrete copy number
gene matrix (from WES data) against the matching
gene’s discrete copy number value from the SNP (or
WGS) gene matrix. Genes whose discrete call differed
significantly against segments from SNP (or WGS)-
based copy number profiling tools were identified as
having a Wilcoxon false discovery rate p-value less than
0.05. Using the plotting capabilities from SWITCHplus,
significantly different genes were highlighted by color on
the copy number frequency landscape plot according to
direction of the alteration (i.e., red for copy number gain
and green for copy number loss).
Jaccard Index (JI), sensitivity, and specificity values are
calculated (per sample) using segment-level CNAs from
WES-based tools and SNP (or WGS) CNAs as the
ground truth value, as previously described [10]. The JI
calculates the amount of concordance between the gen-
omic location of a segment’s ground truth (from SNP or
WGS). Specifically, it uses set theory to represent the
ratio of the intersection of two sets of genome-wide
CNAs to the union of two sets of genome-wide CNAs.
Sensitivity measures the length of overlapping genomic
regions between a tool’s CNAs and the ground truth’s
CNAs divided by the length of the ground truth’s CNAs.
Specificity measures the length of non-overlapping gen-
omic regions between the ground truth’s CNAs and the
tool’s CNAs divided by the length of CNAs not called by
the ground truth. Each resulting JI, sensitivity, and speci-
ficity per sample value is plotted onto a box plot and
separated per copy number profiling tool. For all cohort-
wide box plots, one-sided paired t-tests comparing the
two highest means (excluding SynthEx KNN) are re-
ported to identify whether SynthEx Synthetic Normals
significantly improved the statistical measurement.
ANOVA p values are additionally calculated and re-
ported. For subtype-specific box plots, the ANOVA p
value is reported to identify whether the means differed
significantly among the various tools. All statistics and
graphs were generated using R v.3.3.0.
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